首頁 > 市場調查報告書 > 消費品

健康美容化妝品

市場調查報告書

商品編碼

1654638

全球醫師配發的藥妝品市場 - 2025 至 2033 年

Global Physician Dispensed Cosmeceuticals Market - 2025-2033

出版日期: 2025年02月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球醫師配發的藥妝市場規模達到 365.5 億美元，預計到 2033 年將達到 698.4 億美元，在 2025-2033 年預測期內的複合年成長率為 7.8%。

醫生配發的藥妝品是介於化妝品和藥品之間的產品。與非處方化妝品不同，這些產品是在有醫生監督的環境中分發的，旨在對角質層下的皮膚產生實際的生物效應。此類別涵蓋各種配方，包括針對抗衰老、痤瘡治療和皮膚再生等問題的護膚產品，解決頭皮健康和脫髮的護髮產品，以及包括治療乾眼症或美容增強等病症的眼部護理產品。

全球醫師配發的藥妝市場是指護膚品行業的一個分支，包括僅透過皮膚科醫生和整形外科醫生等醫療專業人士提供的化妝品。這些產品將藥品級成分與化妝品配方結合，提供臨床益處，有效解決特定的皮膚問題，包括老化、痤瘡、色素沉澱和整體皮膚健康。

隨著消費者對有效護膚解決方案的需求不斷上升，在皮膚病學的進步和對專業級產品益處的認知不斷提高的推動下，醫生配發的藥妝市場預計將大幅成長。這些因素推動了全球醫師配發的藥妝市場擴張。

市場動態：

促進因素與約束因素

增強美容意識

美容意識的增強是全球醫師配發的藥妝市場成長的重要驅動力，反映了消費者越來越注重外觀和皮膚健康的廣泛趨勢。這種增強的意識透過幾種關鍵方式影響購買行為並塑造市場動態。

隨著消費者越來越關注皮膚健康，他們尋求的產品不僅能改善外表，還能解決潛在的皮膚問題。這導致人們對醫師配發的藥妝品的興趣日益濃厚，這種藥妝品將藥物級成分與化妝品配方相結合，為衰老、痤瘡和色素沉著等症狀提供臨床效果。消費者對保養品成分的了解越來越深。由於擔心合成化學物質可能帶來的有害影響，人們開始轉向尋求天然和有機成分。現在，許多消費者更喜歡標有清潔或不含有害添加劑的產品，以符合清潔美容運動。

社群媒體平台在增強美容意識方面發揮了至關重要的作用。有影響力的人物和美容專家經常分享他們的護膚程序和產品推薦，讓消費者更了解市場上有效的解決方案。這種趨勢鼓勵人們探索承諾更好效果的醫生配發的產品。隨著美容意識的增強，消費者越來越期望獲得根據其特定需求量身定做的個人化護膚解決方案。這種客製化需求推動品牌不斷創新，提供適合個人皮膚類型和問題的產品。

此外，產業主要參與者推出創新平台和關鍵擴張，將推動全球醫師配製藥妝市場的成長。例如，2024 年 3 月，Elevai Labs 推出了一個電子商務入口網站，以促進其快速成長，成為價值 197 億美元的全球醫師配發藥妝市場的顛覆者。這個新的線上平台允許消費者直接購買 Elevai 的護膚產品，這標誌著其與先前主要透過醫療保健專業人士進行銷售的企業對企業 (B2B) 模式的重大轉變。所有這些因素都要求全球醫師配發藥妝品市場。

此外，2024 年 12 月，Elevai Labs Inc. 推出了 S 系列根部更新系統，標誌著其透過全資子公司 Elevai Skincare Inc. 進軍護髮市場。此外，對護膚技術進步的需求不斷成長，促進了全球醫師配製藥妝市場的擴張。

產品成本高/專業人才短缺

熟練專業人員的短缺是全球醫師配發藥妝市場的一個重大限制因素，影響了該行業有效滿足不斷成長的消費者需求的能力。醫生配發的藥妝品產業目前正面臨嚴重的招募危機。許多企業都難以填補重要職位的空缺，例如皮膚科醫生、美容師和訓練有素的皮膚護理專家。這種短缺限制了能夠分配和推薦有效藥妝產品的合格專業人員的數量，最終影響服務提供和消費者信任。

美容和護膚行業在培訓和資格方面存在明顯差距。學徒制和職業培訓計劃等進入該行業的傳統途徑未能吸引新的人才。隨著消費者擴大尋求根據他們的特定需求量身定做的個人化護膚解決方案，對能夠評估個人皮膚類型並推薦合適的醫師配製產品的熟練專業人員的需求也日益成長。然而，由於合格人才的短缺，滿足這項需求變得越來越具有挑戰性。因此，上述因素可能會限制全球醫師配製藥妝市場的潛在成長。

Physician-dispensed cosmeceuticals are products that exist at the intersection of cosmetics and pharmaceuticals. Unlike over-the-counter cosmetics, these products are dispensed in a medically supervised environment and are intended to produce actual biological effects on the skin beneath the stratum corneum. This category encompasses a variety of formulations, including skincare products targeting issues such as anti-aging, acne treatment, and skin rejuvenation, hair care products addressing scalp health and hair loss, and eye care products including treatments for conditions like dry eye syndrome or cosmetic enhancements.

The global physician-dispensed cosmeceuticals market refers to a segment of the skincare industry that includes cosmetic products available exclusively through healthcare professionals, such as dermatologists and plastic surgeons. These products are formulated to provide clinical benefits by combining pharmaceutical-grade ingredients with cosmetic formulations, effectively addressing specific skin concerns, including aging, acne, hyperpigmentation, and overall skin health.

As consumer demand for effective skincare solutions continues to rise, the market for physician-dispensed cosmeceuticals is expected to grow significantly, driven by advancements in dermatological science and increasing awareness of the benefits of professional-grade products. These factors have driven the global physician-dispensed cosmeceuticals market expansion.

Market Dynamics: Drivers & Restraints

Increasing Beauty Consciousness

Increasing beauty consciousness is a significant driver of growth in the global physician-dispensed cosmeceuticals market, reflecting a broader trend where consumers are becoming more aware of their appearance and skin health. This heightened awareness influences purchasing behaviors and shapes market dynamics in several key ways.

As consumers become more conscious of their skin health, they seek products that not only enhance their appearance but also address underlying skin issues. This has led to a growing interest in physician-dispensed cosmeceuticals, which combine pharmaceutical-grade ingredients with cosmetic formulations to deliver clinical results for conditions like aging, acne, and hyperpigmentation. Consumers are increasingly knowledgeable about the ingredients in their skincare products. There is a shift towards seeking natural and organic ingredients, driven by concerns over the potential harmful effects of synthetic chemicals. Many consumers now prefer products that are labeled as clean or free from harmful additives, aligning with the clean beauty movement.

Social media platforms have played a crucial role in amplifying beauty consciousness. Influencers and beauty experts often share their skincare routines and product recommendations, making consumers more aware of effective solutions available in the market. This trend encourages individuals to explore physician-dispensed products that promise better results. As beauty consciousness rises, consumers increasingly expect personalized skincare solutions tailored to their specific needs. This demand for customization drives brands to innovate and offer products that cater to individual skin types and concerns.

Furthermore, major players in the industry introducing innovative platforms and key expansion that would drive this global physician-dispensed cosmeceuticals market growth. For instance, in March 2024, Elevai Labs launched an e-commerce portal to facilitate its rapid growth as a disruptor in the $19.7 billion global physician-dispensed cosmeceutical market. This new online platform allows consumers to directly purchase Elevai's skincare products, marking a significant shift from its previous business-to-business (B2B) model that primarily involved sales through healthcare professionals. All these factors demand the global physician-dispensed cosmeceuticals market.

Also, in December 2024, Elevai Labs Inc. the S-Series Root Renewal System, marking a significant entry into the hair care market through its wholly owned subsidiary, Elevai Skincare Inc. This innovative system comprises three key components: a shampoo, conditioner, and serum, all designed to promote hair and scalp health at the cellular level using cutting-edge technologies. Moreover, the rising demand for advancements in skincare technology contributes to the global physician-dispensed cosmeceuticals market expansion.

High Costs of Products/Shortage of Skilled Professionals

The shortage of skilled professionals is a significant restraint in the global physician-dispensed cosmeceuticals market, impacting the industry's capacity to effectively meet rising consumer demand. The physician-dispensed cosmeceuticals sector is currently facing a serious recruitment crisis. Many businesses struggle to fill essential roles, such as dermatologists, aesthetic practitioners, and trained skincare specialists. This shortage limits the availability of qualified professionals who can dispense and recommend effective cosmeceutical products, ultimately affecting service delivery and consumer trust.

There are notable gaps in training and qualifications within the beauty and skincare sectors. Traditional pathways into the industry, such as apprenticeships and vocational training programs, are failing to attract new talent. As consumers increasingly seek personalized skincare solutions tailored to their specific needs, there is a growing demand for skilled professionals who can assess individual skin types and recommend appropriate physician-dispensed products. However, with a shortage of qualified personnel, meeting this demand becomes increasingly challenging. Thus, the above factors could be limiting the global physician-dispensed cosmeceuticals market's potential growth.

Segment Analysis

The global physician-dispensed cosmeceuticals market is segmented based on product type, distribution channel, and region.

Product Type:

The skin care products segment is expected to dominate the global physician-dispensed cosmeceuticals market share

The skin care products segment holds a major portion of the global physician-dispensed cosmeceuticals market share and is expected to continue to hold a significant portion of the global physician-dispensed cosmeceuticals market share during the forecast period.

This segment encompasses a variety of formulations designed to address specific skin concerns, leveraging pharmaceutical-grade ingredients that provide clinical benefits. The skin care products segment includes various categories, such as anti-aging products, acne treatment solutions, skin whitening and hyperpigmentation treatments, and dermal fillers. The increasing awareness of skin health and beauty consciousness among consumers drives demand for effective skincare solutions. As individuals become more discerning about their skincare choices, they seek products that not only enhance appearance but also address underlying skin issues.

Furthermore, key players in the industry introducing new products in the market that would drive this segment growth in the global physician-dispensed cosmeceuticals market. For instance, in April 2024, Allergan Aesthetics unveiled two new products under its SkinMedica brand the SkinMedica Acne Clarifying Treatment and the SkinMedica Pore Purifying Gel Cleanser. These innovative products are specifically formulated for individuals with acne-prone skin, providing effective and balanced skincare solutions.

Also, in February 2023, Galderma introduced Alastin Skincare ReSURFACE Skin Polish, a new addition to its scientifically formulated skincare line. This innovative product is designed to improve skin texture by effectively removing dead skin cells and impurities, resulting in smoother and visibly brighter skin.

These factors have solidified the segment's position in the global physician-dispensed cosmeceuticals market.

Geographical Analysis

North America is expected to hold a significant position in the global physician-dispensed cosmeceuticals market share

North America holds a substantial position in the global physician-dispensed cosmeceuticals market and is expected to hold most of the market share.

Consumers are becoming more aware of their appearance and skin health, leading to a heightened demand for effective skincare solutions. This awareness encourages individuals to seek products that not only enhance aesthetics but also address underlying skin issues, driving interest in physician-dispensed cosmeceuticals. Skin diseases, such as acne, affect approximately 50 million people annually in the U.S. The increasing prevalence of various skin conditions creates a demand for specialized products that provide clinical benefits, further propelling market growth.

The aging demographic in North America is contributing to a greater focus on anti-aging treatments. As consumers strive to maintain a youthful appearance, there is a growing demand for products that target signs of aging, such as wrinkles and fine lines. Physician-dispensed cosmeceuticals are recognized for their ability to deliver tangible results due to their pharmaceutical-grade ingredients. Consumers increasingly seek products that provide proven efficacy in treating various skin concerns, which drives them toward these specialized options.

Social media platforms significantly shape consumer perceptions about beauty and skincare products. Influencers and beauty experts often promote physician-dispensed cosmeceuticals, increasing awareness and interest among consumers looking for effective solutions. As beauty consciousness rises, there is an expectation for personalized skincare solutions tailored to individual needs. This trend encourages brands to innovate and offer customized products that cater to specific skin types and concerns.

Furthermore, key player's strategies such as partnerships & collaborations, and launches would drive this global physician-dispensed cosmeceuticals market growth. For instance, in January 2025, Young Pharmaceuticals Inc. announced an exclusive distribution partnership with LAC2Biome, a company specializing in microbial-based product solutions. This collaboration will introduce the BiomeAge product line to the U.S. market, which focuses on a science-driven approach to enhancing skin health.

Also, in October 2023, in California, NovaBay Pharmaceuticals, Inc. launched two new promotional programs aimed at ophthalmologists and optometrists to support their patients in managing chronic dry eye symptoms with Avenova-branded products. The introduction of the Avenova Loyalty Program and the Avenova Affiliate Program provides eyecare professionals with exclusive promotions designed to increase awareness of the complete range of Avenova products. Thus, the above factors are consolidating the region's position as a dominant force in the global physician-dispensed cosmeceuticals market.

Asia Pacific is growing at the fastest pace in the global physician-dispensed cosmeceuticals market share

Asia Pacific holds the fastest pace in the global physician-dispensed cosmeceuticals market and is expected to hold most of the market share.

The prevalence of skin diseases such as acne and hyperpigmentation is on the rise in the Asia-Pacific region. For example, acne affects millions in countries like India and China, creating a demand for specialized products that provide clinical benefits and further propelling market growth. There is a growing awareness among consumers regarding their appearance and skin health. This heightened beauty consciousness drives demand for effective skincare solutions that not only enhance aesthetics but also address underlying skin issues, leading to increased interest in physician-dispensed cosmeceuticals.

Physician-dispensed cosmeceuticals are recognized for their ability to deliver tangible results due to their pharmaceutical-grade ingredients. Consumers are increasingly seeking products that provide proven efficacy in treating various skin concerns, driving them toward these specialized options. Social media platforms play a crucial role in shaping consumer perceptions about beauty and skincare products in the Asia-Pacific region. Influencers and beauty experts often promote physician-dispensed cosmeceuticals, increasing awareness and interest among consumers looking for effective solutions.

Furthermore, key players in the industry introducing new products in the market drive this global physician-dispensed cosmeceuticals market growth. For instance, in January 2025, Obagi Medical launched its products in India through a partnership with Nykaa, the country's premier beauty and lifestyle platform. This collaboration marks a significant milestone in providing high-quality skincare solutions to Indian consumers. With over 30 years of expertise, Obagi Medical is known for its clinically proven products that effectively address various skin concerns, including aging, hyperpigmentation, and uneven skin tone.

Also, in December 2024, Hydrinity Accelerated Skin Science launched its products in India through a partnership with Photonence, a company recognized for its innovative healthcare distribution solutions. This collaboration aims to introduce Hydrinity's range of hyaluronic acid skincare products to the Indian market, leveraging Photonence's expertise and established presence in the medical aesthetics sector. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global physician-dispensed cosmeceuticals market.

Competitive Landscape

The major global players in the physician-dispensed cosmeceuticals market include Allergan (AbbVie Inc.), Merz Pharma, Obagi Cosmeceuticals LLC., L'Oreal Groupe, SkinCeuticals., ZO Skin Health, Inc., JMSR, Inc., La Roche-Posay, Galderma, ELEVAI Labs, Inc., Sebapharma, Cosmetic Skin Solutions., AestheticsRX, and RATIONALE. among others.

Key Developments

In January 2025, Carmell Corporation announced its entry into a definitive purchase agreement to acquire the assets of Elevai Skincare Inc., a subsidiary of PMGC Holdings Inc. This acquisition is aimed at enhancing Carmell's portfolio in the skincare and haircare sectors.
In December 2024, CALECIM, officially entered the Indian market, marking a significant milestone in the country's hair restoration industry. This launch is supported by CellResearch Corporation, a pioneering biotechnology firm known for its groundbreaking work in stem cell research over the past two decades.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global physician-dispensed cosmeceuticals market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Distribution channel
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Beauty Consciousness
- 4.1.2. Restraints
  - 4.1.2.1. High Costs of Products/Shortage of Skilled Professionals
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Product Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Skin Care Products*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Anti-Aging
- 6.2.4. Sunscreens
- 6.2.5. Acne
- 6.2.6. Hydrating Creams & Serums
- 6.2.7. Dermal Fillers
- 6.2.8. Others
6.3. Hair Care Products
- 6.3.1. Hair Growth Stimulants
- 6.3.2. Anti-Dandruff
- 6.3.3. Scalp Repair Solutions
- 6.3.4. Others
6.4. Eye Care Products
- 6.4.1. Eye Drops
- 6.4.2. Eye Creams & Gels
- 6.4.3. Others
6.5. Others

7. By Distribution channel

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution channel
- 7.1.2. Market Attractiveness Index, By Distribution channel
7.2. Hospital Pharmacies*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Retail Pharmacies
7.4. Online Pharmacies

8. By Region

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 8.1.2. Market Attractiveness Index, By Region
8.2. North America
- 8.2.1. Introduction
- 8.2.2. Key Region-Specific Dynamics
- 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution channel
- 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.2.5.1. U.S.
  - 8.2.5.2. Canada
  - 8.2.5.3. Mexico
8.3. Europe
- 8.3.1. Introduction
- 8.3.2. Key Region-Specific Dynamics
- 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution channel
- 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.3.5.1. Germany
  - 8.3.5.2. U.K.
  - 8.3.5.3. France
  - 8.3.5.4. Spain
  - 8.3.5.5. Italy
  - 8.3.5.6. Rest of Europe
8.4. South America
- 8.4.1. Introduction
- 8.4.2. Key Region-Specific Dynamics
- 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution channel
- 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.4.5.1. Brazil
  - 8.4.5.2. Argentina
  - 8.4.5.3. Rest of South America
8.5. Asia-Pacific
- 8.5.1. Introduction
- 8.5.2. Key Region-Specific Dynamics
- 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution channel
- 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.5.5.1. China
  - 8.5.5.2. India
  - 8.5.5.3. Japan
  - 8.5.5.4. South Korea
  - 8.5.5.5. Rest of Asia-Pacific
8.6. Middle East and Africa
- 8.6.1. Introduction
- 8.6.2. Key Region-Specific Dynamics
- 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution channel

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

10.1. Allergan (AbbVie Inc.) *
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio
  - 10.1.2.1. Product Description
  - 10.1.2.2. Product Key Performance Indicators (KPIs)
  - 10.1.2.3. Historic and Forecasted Product Sales
  - 10.1.2.4. Product Sales Volume
- 10.1.3. Financial Overview
  - 10.1.3.1. Company Revenue's
  - 10.1.3.2. Geographical Revenue Shares
  - 10.1.3.3. Revenue Forecasts
- 10.1.4. Key Developments
  - 10.1.4.1. Mergers & Acquisitions
  - 10.1.4.2. Key Product Development Activities
  - 10.1.4.3. Regulatory Approvals etc.
- 10.1.5. SWOT Analysis
10.2. Merz Pharma
10.3. Obagi Cosmeceuticals LLC.
10.4. L'Oreal Groupe
10.5. SkinCeuticals.
10.6. ZO Skin Health, Inc.
10.7. JMSR, Inc.
10.8. La Roche-Posay
10.9. Galderma
10.10. ELEVAI Labs, Inc.
10.11. Sebapharma
10.12. Cosmetic Skin Solutions.
10.13. AestheticsRX
10.14. RATIONALE.